536565
TRIMURTHI
Invest Now
Start SIP in
TRIMURTHI
Performance
- Low
- ₹28
- High
- ₹28
- 52 Week Low
- ₹18
- 52 Week High
- ₹28
- Open Price₹28
- Previous Close₹27
- Volume1,009
Investment Returns
- Over 1 Month + 5%
- Over 3 Month + 10.22%
- Over 6 Month + 21.48%
- Over 1 Year + 54.88%
Smart Investing Starts Here Start SIP with Novelix Pharmaceuticals for Steady Growth!
Novelix Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 141
- PEG Ratio
- 0.8
- Market Cap Cr
- 28
- P/B Ratio
- 3
- Average True Range
- 0.23
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 1.36
- RSI
- 99.66
- MFI
- 100
Novelix Pharmaceuticals Financials
Novelix Pharmaceuticals Technicals
EMA & SMA
Current Price
₹27.94
+
1.33
(5%)

-
- Bearish Moving Average 0
-
- Bullish Moving Average 16
- 20 Day
- ₹25.61
- 50 Day
- ₹22.75
- 100 Day
- ₹19.23
- 200 Day
- ₹15.65
Resistance and Support
27.94
- R3 27.94
- R2 27.94
- R1 27.94
- S1 27.94
- S2 27.94
- S3 27.94
Novelix Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-04-12 | Others | Inter-alia, to consider 1. Convening of an EGM for appointment of Non-Executive Independent Director of the Company. 2. To appoint a scrutinizer for the upcoming EGM. 3. Other business matters. |
2025-02-12 | Quarterly Results | |
2024-11-13 | Quarterly Results & Others | Inter-alia, 1. To take note of the Certificate of Whole Time Director & Chief Financial Officer of the Company for the quarter and half year ended 30th September 2024. |
2024-10-21 | To consider issue of Warrants | (Revised) |
2024-09-02 | Others | Inter alia, to consider 1. Amendment of Main Objects of the Company. 2. Change in name of the Company. 3. Change in the Registered Office of the Company. |
Novelix Pharmaceuticals F&O
About Novelix Pharmaceuticals
- NSE Symbol
- TRIMURTHI
- BSE Symbol
- 536565
- ISIN
- INE314I01036
Similar Stocks to Novelix Pharmaceuticals
Novelix Pharmaceuticals FAQs
Novelix Pharmaceuticals share price is ₹27 As on 19 May, 2025 | 05:12
The Market Cap of Novelix Pharmaceuticals is ₹27.8 Cr As on 19 May, 2025 | 05:12
The P/E ratio of Novelix Pharmaceuticals is 141 As on 19 May, 2025 | 05:12
The PB ratio of Novelix Pharmaceuticals is 3 As on 19 May, 2025 | 05:12
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.